Literature DB >> 20434463

Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases.

Yanqi Chang1, Thota Ganesh, John R Horton, Astrid Spannhoff, Jin Liu, Aiming Sun, Xing Zhang, Mark T Bedford, Yoichi Shinkai, James P Snyder, Xiaodong Cheng.   

Abstract

Dynamic histone lysine methylation involves the activities of modifying enzymes (writers), enzymes removing modifications (erasers), and readers of the histone code. One common feature of these activities is the recognition of lysines in methylated and unmethylated states, whether they are substrates, reaction products, or binding partners. We applied the concept of adding a lysine mimic to an established inhibitor (BIX-01294) of histone H3 lysine 9 methyltransferases G9a and G9a-like protein by including a 5-aminopentyloxy moiety, which is inserted into the target lysine-binding channel and becomes methylated by G9a-like protein, albeit slowly. The compound enhances its potency in vitro and reduces cell toxicity in vivo. We suggest that adding a lysine or methyl-lysine mimic should be considered in the design of small-molecule inhibitors for other methyl-lysine writers, erasers, and readers. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434463      PMCID: PMC2895764          DOI: 10.1016/j.jmb.2010.04.048

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring.

Authors:  Paul D Lyne; Michelle L Lamb; Jamal C Saeh
Journal:  J Med Chem       Date:  2006-08-10       Impact factor: 7.446

4.  Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.

Authors:  Stefan Kubicek; Roderick J O'Sullivan; E Michael August; Eugene R Hickey; Qiang Zhang; Miguel L Teodoro; Stephen Rea; Karl Mechtler; Jennifer A Kowalski; Carol Ann Homon; Terence A Kelly; Thomas Jenuwein
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

Review 5.  Chemical probes for histone-modifying enzymes.

Authors:  Philip A Cole
Journal:  Nat Chem Biol       Date:  2008-10       Impact factor: 15.040

6.  MM-GB/SA rescoring of docking poses in structure-based lead optimization.

Authors:  Cristiano R W Guimarães; Mario Cardozo
Journal:  J Chem Inf Model       Date:  2008-04-19       Impact factor: 4.956

7.  A novel ES cell line, TT2, with high germline-differentiating potency.

Authors:  T Yagi; T Tokunaga; Y Furuta; S Nada; M Yoshida; T Tsukada; Y Saga; N Takeda; Y Ikawa; S Aizawa
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

8.  A modified synthesis of iodoazidoaryl prazosin.

Authors:  Merritt B Andrus; Sashikumar N Mettath; Chun Song
Journal:  J Org Chem       Date:  2002-11-15       Impact factor: 4.354

9.  Essential role of the histone methyltransferase G9a in cocaine-induced plasticity.

Authors:  Ian Maze; Herbert E Covington; David M Dietz; Quincey LaPlant; William Renthal; Scott J Russo; Max Mechanic; Ezekiell Mouzon; Rachael L Neve; Stephen J Haggarty; Yanhua Ren; Srihari C Sampath; Yasmin L Hurd; Paul Greengard; Alexander Tarakhovsky; Anne Schaefer; Eric J Nestler
Journal:  Science       Date:  2010-01-08       Impact factor: 47.728

10.  Structural biology of human H3K9 methyltransferases.

Authors:  Hong Wu; Jinrong Min; Vladimir V Lunin; Tatiana Antoshenko; Ludmila Dombrovski; Hong Zeng; Abdellah Allali-Hassani; Valérie Campagna-Slater; Masoud Vedadi; Cheryl H Arrowsmith; Alexander N Plotnikov; Matthieu Schapira
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more
  51 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 2.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

Review 3.  H3K9 methyltransferase G9a and the related molecule GLP.

Authors:  Yoichi Shinkai; Makoto Tachibana
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

Review 4.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

5.  Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.

Authors:  Yan Xiong; Fengling Li; Nicolas Babault; Hong Wu; Aiping Dong; Hong Zeng; Xin Chen; Cheryl H Arrowsmith; Peter J Brown; Jing Liu; Masoud Vedadi; Jian Jin
Journal:  Bioorg Med Chem       Date:  2017-06-19       Impact factor: 3.641

Review 6.  G9a, a multipotent regulator of gene expression.

Authors:  Shilpa Rani Shankar; Avinash G Bahirvani; Vinay Kumar Rao; Narendra Bharathy; Jin Rong Ow; Reshma Taneja
Journal:  Epigenetics       Date:  2012-12-20       Impact factor: 4.528

Review 7.  Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules.

Authors:  Pilar Blancafort; Jian Jin; Stephen Frye
Journal:  Mol Pharmacol       Date:  2012-11-13       Impact factor: 4.436

8.  An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

Authors:  Kyle D Konze; Anqi Ma; Fengling Li; Dalia Barsyte-Lovejoy; Trevor Parton; Christopher J Macnevin; Feng Liu; Cen Gao; Xi-Ping Huang; Ekaterina Kuznetsova; Marie Rougie; Alice Jiang; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Bryan L Roth; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Klaus M Hahn; Gang Greg Wang; Masoud Vedadi; Jian Jin
Journal:  ACS Chem Biol       Date:  2013-04-24       Impact factor: 5.100

9.  Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors.

Authors:  Feng Liu; Fengling Li; Anqi Ma; Elena Dobrovetsky; Aiping Dong; Cen Gao; Ilia Korboukh; Jing Liu; David Smil; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Matthieu Schapira; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2013-02-27       Impact factor: 7.446

10.  Histone mimics: digging down under.

Authors:  Yiwei Lin; Binhua P Zhou
Journal:  Front Biol (Beijing)       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.